IP Library Granted Patent US 10,890,529
Granted Patent B2
US 10,890,529 · App. 16/788,588 · Granted Jan 12, 2021

Duplex stabilizing fluorescence quenchers for nucleic acid probes

Inventors: Eugeny A. Lukhtanov (Bothell, WA); Noah Scarr (Seattle, WA)
Assignee: ELITECHGROUP, INC.
G01N21/6428C07D403/10C07D487/04C07H21/04C08L77/02C12Q1/6832G01N2021/6432G01N2021/6439
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,890,529
App. No.
16/788,588
Granted
Jan 12, 2021
Kind
B2
Abstract

Diaryl-azo derivatives are efficient fluorescence quenchers as well as nucleic acid duplex-stabilizing agents and are useful in oligonucleotide conjugates and probes. The oligonucleotide-quencher conjugates may be used in detection methods for nucleic acid targets.

Claims (19)

1. An oligonucleotide conjugate comprising a fluorescence quenching compound and having the formula:

wherein ODN is an oligonucleotide;

L is a linking group;

R 1 is H, alkyl, or alkyl covalently connected to Ar 3

Ar 1 and Ar 2 are aromatic or hetero-aromatic moieties;

Ar 3 is an aromatic moiety selected from substituted or unsubstituted indole, benzofuran, benzothiophene and benzoselenophene;

R 3 is hydroxyl, a linking group, or a blocking group; and

n is from 1 to 5.

2. The oligonucleotide conjugate of claim 1 , wherein the oligonucleotide comprises a fluorophore connected to the oligonucleotide.

3. The oligonucleotide conjugate of claim 2 , wherein the fluorophore is FAM, AP525, AP559, AP593 or AP662.

4. The oligonucleotide conjugate of claim 1 , wherein the oligonucleotide comprises a minor groove binder connected to the oligonucleotide.

5. The oligonucleotide conjugate of claim 1 , wherein the oligonucleotide comprises one or more modified nucleobases or modified bases.

6. The oligonucleotide conjugate of claim 1 , wherein L is connected to the oligonucleotide at a 3′-end.

7. The oligonucleotide conjugate of claim 1 , wherein L is connected to the oligonucleotide at a 5′-end.

8. The oligonucleotide conjugate of claim 1 , wherein L is connected to the oligonucleotide at a position other than a 3′- or 5′-end.

9. The oligonucleotide conjugate of claim 1 having the formula:

wherein n is 1, 2, or 3.

10. The oligonucleotide conjugate of claim 1 having the formula:

wherein n is 1, 2, or 3.

Assignments (3)
NUNC PRO TUNC ASSIGNMENT Recorded Jan 11, 2022
From: ELITECHGROUP, INC.
To: ELITECHGROUP MDX LLC
Reel/Frame 058615/0341 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 12, 2020
From: LUKHTANOV, EUGENY A.; SCARR, NOAH
To: ELITECHGROUP B.V.
Reel/Frame 051795/0147 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 12, 2020
From: ELITECHGROUP B.V.
To: ELITECHGROUP, INC.
Reel/Frame 051795/0235 →
Continuity (3)
Division 16057016 · Aug 7, 2018
Provisional Application 62546965 · Aug 17, 2017
Related Publication 20200173924A1 · Jun 4, 2020